Back to Search Start Over

Immunomodulatory activities of isolated compounds from the root-bark of Cussonia arborea.

Authors :
Oladimeji, Abdulkabir Oladele
Oladosu, Ibrahim Adebayo
Jabeen, Almas
Faheem, Aisha
Mesaik, Mohammed Ahmed
Ali, Muhammad Shaiq
Source :
Pharmaceutical Biology; Dec2017, Vol. 55 Issue 1, p2240-2247, 8p
Publication Year :
2017

Abstract

Context:Cussonia arboreaHochst. ex A. Rich (Araliaceae) is a folk medicine used to treat various diseases. However, there is no report of the root phytochemistry. Objective:This study isolates and identifies the immunomodulatory compounds from root-bark ofC. arborea. Materials and methods:The methanol extract (18 g) was subjected to repeated column chromatography resulting in isolation of five compounds (1–5). Structure determination was achieved by analysis of their 1 D and 2 D NMR, and mass spectroscopy. The compounds (100–1.0 μg/mL) were examined immunomodulatory for effect on production of reactive oxygen species (ROS) from whole blood phagocytes and on proliferation of T-cells. The compounds cytotoxicity (100–1.0 μg/mL) was evaluated on NIH-3T3 normal fibroblast cells. Results:Three pentacyclic triterpenoids [3, 23-dihydroxy-12-oleanen-28-oic acid (1), 3β-hydroxylolean-12-en-28-oic (2) and 23-hydoxy-oxo-urs-12-en-28-oic acid (5)], two phytosterols: [stigmasterol (3)] and [3-O-β-d-glucopyranosyl stigmasterol (4)] were all isolated from the methanol soluble extract. All the tested compounds (1–4) were found to be nontoxic on NIH-3T3 cells. Compound1and2moderately inhibited the production of ROS (IC50 = 24.4 ± 4.3 and 37.5 ± 0.1 μg/mL, respectively) whereas compound2exhibited the highest inhibitory effect (IC50 = 12.6 ± 0.4 μg/mL) on proliferation of phytoheamagglutinin (PHA) activated T-cells. Conclusions:The isolated compounds (1–5) are reported for the first time from this species. In addition, compound2with suppressive potential on production of intracellular ROS and proliferation of T-cells could be of immense value in control of autoimmune diseases as well as in immune compromised patients. [ABSTRACT FROM PUBLISHER]

Details

Language :
English
ISSN :
13880209
Volume :
55
Issue :
1
Database :
Complementary Index
Journal :
Pharmaceutical Biology
Publication Type :
Academic Journal
Accession number :
126815856
Full Text :
https://doi.org/10.1080/13880209.2017.1400078